Showing results (91-100 of 113) with videos related to
Sort By:
Pageof 12
Modern Rheumatology|January 7, 2020
Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC studyYoshiya Tanaka, Hideto Kameda, Kazuyoshi Saito, et al.Arthritis Research & Therapy|July 22, 2018
Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC studyYoshiya Tanaka, Hideto Kameda, Kazuyoshi Saito, et al.Modern Rheumatology|November 17, 2016
Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in JapanHayato Yamazaki, Fumio Hirano, Tsutomu Takeuchi, et al.Annals of the Rheumatic Diseases|November 8, 2019
First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohortMasatoshi Jinnin, Akiko Ohta, Shoichiro Ishihara, et al.Plos One|January 24, 2014
The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumoniaRan Nakashima, Yoshitaka Imura, Yuji Hosono, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 4, 2015
Temporal expression of growth factors triggered by epiregulin regulates inflammation developmentMasaya Harada, Daisuke Kamimura, Yasunobu Arima, et al.Cell Reports|February 26, 2013
Disease-association analysis of an inflammation-related feedback loopMasaaki Murakami, Masaya Harada, Daisuke Kamimura, et al.Arthritis Research & Therapy|September 25, 2014
Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of miceWaka Yokoyama, Hitoshi Kohsaka, Kayoko Kaneko, et al.Arthritis Care & Research|April 3, 2015
Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid ArthritisAtsushi Ogata, Tatsuya Atsumi, Takaaki Fukuda, et al.Modern Rheumatology|December 7, 2016
Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategyFumio Hirano, Waka Yokoyama, Hayato Yamazaki, et al.Pageof 12